-
1
-
-
0030143921
-
Perspectives on treatment needs in schizophrenia
-
Meise U, Fleischhacker WW. Perspectives on treatment needs in schizophrenia. Br J Psychiatr 1996; 168 (Suppl 29):9-16.
-
(1996)
Br J Psychiatr
, vol.168
, Issue.29 SUPPL.
, pp. 9-16
-
-
Meise, U.1
Fleischhacker, W.W.2
-
2
-
-
0032818246
-
Patient satisfaction and acceptability of long-term treatment with quetiapine
-
Hellewell JSE, Kalali AH, Langham SJ, McKellar J, Awad AG. Patient satisfaction and acceptability of long-term treatment with quetiapine. Int J Psychiatr Clin Pract 1999; 3(2):97-105.
-
(1999)
Int J Psychiatr Clin Pract
, vol.3
, Issue.2
, pp. 97-105
-
-
Hellewell, J.S.E.1
Kalali, A.H.2
Langham, S.J.3
McKellar, J.4
Awad, A.G.5
-
3
-
-
0030795988
-
Multiple fixed doses of Seroquel in patients with acute exacerbation of schizophrenia a comparison with haloperidol and placebo
-
Arvanitis LA, Miller BG, Seroquel Trial 13 Study Group. Multiple fixed doses of Seroquel in patients with acute exacerbation of schizophrenia a comparison with haloperidol and placebo. Biol Psychiatr 1997; 42:233-246.
-
(1997)
Biol Psychiatr
, vol.42
, pp. 233-246
-
-
Arvanitis, L.A.1
Miller, B.G.2
-
4
-
-
1642599803
-
'Seroquel' (quetiapine): Extrapyramidal symptoms in general and elderly psychotic patient populations
-
31 October - 4 November, Paris, France
-
Yeung PP, Goldstein JM, Hellewell JSE, Atkinson GA. 'Seroquel' (quetiapine): extrapyramidal symptoms in general and elderly psychotic patient populations. Poster presented at 1988 European Congress of Neuropsychopharmacology, 31 October - 4 November, Paris, France.
-
1988 European Congress of Neuropsychopharmacology
-
-
Yeung, P.P.1
Goldstein, J.M.2
Hellewell, J.S.E.3
Atkinson, G.A.4
-
5
-
-
0029893011
-
An essay on the use of new antipsychotics
-
Kerwin RW An essay on the use of new antipsychotics. Psychol Bull 1996; 20:23-29.
-
(1996)
Psychol Bull
, vol.20
, pp. 23-29
-
-
Kerwin, R.W.1
-
6
-
-
0031794339
-
Haematological safety of antipsychotic drugs
-
King DJ, Wagner E. Haematological safety of antipsychotic drugs. J Psychopharmacol 1998; 12:283-288.
-
(1998)
J Psychopharmacol
, vol.12
, pp. 283-288
-
-
King, D.J.1
Wagner, E.2
-
7
-
-
0025049829
-
A prospective, multicenter study of patients' refusal of antipsychotic medication
-
Hoge SK, Appelbaum PS, Lawlor T, Beck JC, Litman R, Green A et al. A prospective, multicenter study of patients' refusal of antipsychotic medication. Arch Gen Psychiatr 1990; 47:949-956.8.
-
(1990)
Arch Gen Psychiatr
, vol.47
, pp. 949-956
-
-
Hoge, S.K.1
Appelbaum, P.S.2
Lawlor, T.3
Beck, J.C.4
Litman, R.5
Green, A.6
-
8
-
-
1642630819
-
Schizophrenia treatment and its associated side effects: The attitudes and perceptions of healthcare professionals, patients and their carers
-
15 - 20 May, Washington, DC, abstract no. NR 653
-
Hellewell JSE. Schizophrenia treatment and its associated side effects: the attitudes and perceptions of healthcare professionals, patients and their carers. 1999 Annual Meeting of American Psychiatric Association, 15 - 20 May, Washington, DC, abstract no. NR 653, p 253.
-
1999 Annual Meeting of American Psychiatric Association
, pp. 253
-
-
Hellewell, J.S.E.1
-
9
-
-
1642599800
-
A double-blind, flexible dose comparative study of risperidone and haloperidol in first-episode schizophrenia and schizophreniform disorder
-
in press
-
Emsley RA, Risperidone Group. A double-blind, flexible dose comparative study of risperidone and haloperidol in first-episode schizophrenia and schizophreniform disorder. Schizophr Bull 1999; in press.
-
(1999)
Schizophr Bull
-
-
Emsley, R.A.1
-
10
-
-
0030843514
-
Tardive dyskinesia: Who is at risk?
-
Van Os J, Fahy T, Jones P, Harvey I, Toone B, Murray R. Tardive dyskinesia: who is at risk? Acta Psychiatr Scand 1997; 96(3):206-216.
-
(1997)
Acta Psychiatr Scand
, vol.96
, Issue.3
, pp. 206-216
-
-
Van Os, J.1
Fahy, T.2
Jones, P.3
Harvey, I.4
Toone, B.5
Murray, R.6
-
11
-
-
1642615399
-
Tardive dyskenesia: Are women more at risk?
-
in press
-
Van Os J, Gilvarry C, Bale R, Van Horn E, Tattan T, White I et al. on behalf of the UK700 Group. Tardive dyskenesia: are women more at risk? Acta Psychiatr Scand 1999; in press.
-
(1999)
Acta Psychiatr Scand
-
-
Van Os, J.1
Gilvarry, C.2
Bale, R.3
Van Horn, E.4
Tattan, T.5
White, I.6
-
13
-
-
0019159150
-
Decreased bone density in hyperprolactinemic women
-
Klibanski A, Neer RM, Beitins IZ, Ridgway EC, Zervas NT, McArthur JW. Decreased bone density in hyperprolactinemic women. N Engl J Med 1980; 303: 1511-1514.
-
(1980)
N Engl J Med
, vol.303
, pp. 1511-1514
-
-
Klibanski, A.1
Neer, R.M.2
Beitins, I.Z.3
Ridgway, E.C.4
Zervas, N.T.5
McArthur, J.W.6
-
14
-
-
0025681487
-
Subjective utility ratings of neuroleptics in treating schizophrenia
-
Finn SE, Bailey JM Schultz RT, Faber R. Subjective utility ratings of neuroleptics in treating schizophrenia. Psychol Med 1990; 20:843-848.
-
(1990)
Psychol Med
, vol.20
, pp. 843-848
-
-
Finn, S.E.1
Bailey, J.M.2
Schultz, R.T.3
Faber, R.4
-
15
-
-
0030671093
-
Schizophrenia, antipsychotic drugs and sexual function
-
Baldwin D, Birtwistle J. Schizophrenia, antipsychotic drugs and sexual function. Primary Care Psychiatr 1997; 3:115-123.
-
(1997)
Primary Care Psychiatr
, vol.3
, pp. 115-123
-
-
Baldwin, D.1
Birtwistle, J.2
-
16
-
-
0026517008
-
The concept of recovery and secondary prevention in psychotic disorders
-
McGorry PD. The concept of recovery and secondary prevention in psychotic disorders. Aust NZ J Psychiatr 1992; 26:3-17.
-
(1992)
Aust NZ J Psychiatr
, vol.26
, pp. 3-17
-
-
McGorry, P.D.1
-
17
-
-
0031957987
-
Neuroleptic management of schizophrenia: A survey and commentary on Australian psychiatric practice
-
Parker G, Lambert R, McGrath J, McGorry P, Tiller J. Neuroleptic management of schizophrenia: a survey and commentary on Australian psychiatric practice. Aust NZ J Psychiatr 1998; 32:50-58.
-
(1998)
Aust NZ J Psychiatr
, vol.32
, pp. 50-58
-
-
Parker, G.1
Lambert, R.2
McGrath, J.3
McGorry, P.4
Tiller, J.5
|